Now live: FDA · Health Canada · EU/UK 1169 · Gulf GSO · FSANZ · Swiss LIV · India FSSAI · Eurasian TR CU 022 · East African EAS 38 · CARICOM CRS 5 · MERCOSUR / ANVISA · Japan CAA label formats · true-scale KLD dielines · multilingual ingredient intelligence
regulatory

Safety of benfotiamine as a Novel food pursuant to Regulation (EU) 2015/2283 and the bioavailability of benfotiamine as a source of thiamin in the context of Directive 2002/46/EC on food supplements

EFSA (European Food Safety Authority) · European Union · published 09 Oct 2026

Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of benfotiamine as a novel food (NF) pursuant to Regulation (EU) 2015/2283 and on the bioavailability of benfotiamine as a source of thiamin in the context of Directive 2002/46/EC. The NF, which is produced by chemical synthesis, is proposed to be used in food supplements for adults at a maximum intake of 300 mg/day.

Read the official notice →

Source: EFSA (European Food Safety Authority) · EFSA reuse policy (attribution). This is a short, attributed summary; the full authoritative text lives on the authority’s own site. LabelYog does not author or endorse it — confirm compliance against the destination market’s official source.

More from European Union

Labelling rules for this market

LabelYog has not assessed whether this notice changes what a pack must carry; the official notice is the authority. These are the rules we build against, starting with EU 1169.

← All food-authority news